476
Participants
Start Date
June 30, 2005
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Imatinib mesylate
Imatinib is packaged in bottles as 100mg and 400mg tablets
Roswell Park Cancer Institute, Buffalo
Western Pennsylvania Hospital, Pittsburgh
University of Pittsburg, Hillman Cancer Center, Pittsburgh
St. Agnes Hospital, Baltimore
University of Virgina Cancer Center, UVA Division of Hematology & Oncology, Charlottesville
Wake Forest University Health Sciences, Winston-Salem
Duke University Medical Center, Durham
MUSC Hollings Cancer Center, Charleston
Cancer Center of the Carolinas, Greenville
Cancer Center of the Carolinas, Greenville
Cancer Centers of the Carolinas, Greenville
Integrated Community Oncology Network, Orange Park
Hematology-Oncology Associates, P.A., Pensacola
Osler Medical Inc., Melbourne
Advanced Medical Specialists, Miami
Palm Beach Cancer Institute, West Palm Beach
University of South Alabama, Mobile
Sarah Cannon Research Institute, Nashville
The Jones Clinic, Germantown
Lousville Oncology, Clinical Research Program M-25, Louisville
University of Kentucky - C201 Clinic, Lexington
University of Kentucky, Lexington
University Hospitals of Cleveland, Case Comprehensive Cancer Center, Cleveland
Cleveland Clinic Foundation, Cleveland
Indiana Blood and Marrow Institutw, Beech Grove
Indiana Blood and Marrow Transplant, Beech Grove
Great Lakes Cancer Institute, Lansing
University of Iowa Hospitals & Clinic, Iowa City
U of Minnesota, Minneapolis
University of Minnesota, Minneapolis
Rush University Medical Center, Chicago
Jayne S. Gurtler, MD, Laura A. Brinz, MD & Angelo Russo, MD, Metairie
Hematology and Oncology Specialists, New Orleans
LSU Health Science Center, Shreveport
LSU Health Scine Center, Shreveport
UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas
MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Center, Denver
San Juan Oncology Associates, Farmington
UCLA Medical Center, Los Angeles
Alta Bates Comprehsenive Cancer Center, Berkeley
University of Miami, Berkeley
South Bay Oncology Hematology Partners, Campbell
Cancer Research Center of Hawaii, Honolulu
Kaiser Permanente Northwest Region Oncology/Hemacology, Portland
Kaiser Permanente Northwest Region, Portland
Palm Beach Cancer Institute, West Palm Beach
Cancer Center at Hackensack University Medical Center, Hackensack
Hackensack University Medical Center, Hackensack
University of Texas / MD Anderson Cancer Center, Houston
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, La Plata
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Waratah
Novartis Investigative Site, Westmead
Novartis Investigative Site, Herston
Novartis Investigative Site, Woolloongabba
Novartis Investigative Site, Adelaide
Novartis Investigative Site, East Melbourne
Novartis Investigative Site, Fitzroy
Novartis Investigative Site, Frankston
Novartis Investigative Site, Parkville
Novartis Investigative Site, Prahran
Novartis Investigative Site, South Brisbane
Novartis Investigative Site, Campinas
Novartis Investigative Site, Calgary
Novartis Investigative Site, Montreal
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Québec
Novartis Investigative Site, Bologna
Novartis Investigative Site, Florence
Novartis Investigative Site, Milan
Novartis Investigative Site, Napoli
Novartis Investigative Site, Orbassano
Novartis Investigative Site, Roma
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY